NxStage Stock Receives a Third Buy Rating in a Row
BTIG, Piper Jaffray, and Northland Securities have all assigned Buy ratings to NxStage, which trades as NXTM on the NASDAQ. In the past quarter, more insiders have been buying the stock.
Read the full article » | Posted 04-12-2017
Related Articles
- Vantive: Real People, Real Stories on PD Empowers Site for Patients Posted 12-17-2025
- Medicare Fee Schedule Final Rule Summary: CY 2026 Posted 12-17-2025
- Medicare Deductible, Coinsurance & Premium Rates for 2026 Posted 12-17-2025
- Watch Dr. Joel Glickman’s ASN presentation on Home HD Prescriptions Posted 12-17-2025

